← Leaderboards
Patrick Christopher Wilson
Oklahoma Medical Research Foundation
$19,347,619
Attributed
$19,711,068
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,711,068 · 18
By mechanism
U19$11,577,134 · 8
P01$4,332,406 · 2
R01$2,255,387 · 2
P20$1,546,141 · 6
Top collaborators
- Maria Virginia Pascual1 shared
Others in their field
Top investigators on “Specificity”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Eric S Lander · Whitehead Institute For Biomedical Res$527,312,131
- Barton F Haynes · Duke University$483,626,898
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$395,980,920
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$381,706,339
Research focus
SpecificityB-LymphocytesAntibodiesCellsMonoclonal AntibodiesAntigensResponseTechnologyGenesEpitopesImmunityVaccinesAffinityInsightSourceRecombinantsVaccinationSerumAntibody FormationCohortPathologyBinding (Molecular Function)MediatingHuman Monoclonal Antibodies
Grant awards (61)
Personalized Immunomonitoring to Understand Juvenile Dermatomyositis$726,898
R01 · FY2025 · AR
Principal Project: B cell response underlying Celiac disease antibody and autoantibody responses$236,168
U19 · FY2023 · AI · contact PI
Monoclonal Antibody Technology Core$405,000
P01 · FY2022 · AI · contact PI
Principal Project: B cell response underlying Celiac disease antibody and autoantibody responses$243,000
U19 · FY2022 · AI · contact PI
Monoclonal Antibody Technology Core$405,000
P01 · FY2021 · AI · contact PI
Principal Project: B cell response underlying Celiac disease antibody and autoantibody responses$243,000
U19 · FY2021 · AI · contact PI
Monoclonal Antibody Technology Core$405,000
P01 · FY2020 · AI · contact PI
Principal Project: B cell response underlying Celiac disease antibody and autoantibody responses$242,999
U19 · FY2020 · AI · contact PI
Monoclonal Antibody Technology Core$405,000
P01 · FY2019 · AI · contact PI
Principal Project: B cell response underlying Celiac disease antibody and autoantibody responses$243,000
U19 · FY2019 · AI · contact PI
Monoclonal Antibody Technology Core$422,375
P01 · FY2018 · AI · contact PI
Understanding Human B Cell Responses to Influenza to Improve the Influenza$343,170
U19 · FY2018 · AI · contact PI
Monoclonal Antibody Core$201,170
U19 · FY2018 · AI · contact PI
Exploring the mechanistic basis for altered peripheral B cell selection in SLE$79,000
U19 · FY2018 · AI · contact PI
Understanding Human B Cell Responses to Influenza to Improve the Influenza$343,170
U19 · FY2017 · AI · contact PI
Exploring the mechanistic basis for altered peripheral B cell selection in SLE$296,899
U19 · FY2017 · AI · contact PI
Monoclonal Antibody Core$201,170
U19 · FY2017 · AI · contact PI
Monoclonal Antibody Technology Core$497,686
P01 · FY2016 · AI · contact PI
Understanding Human B Cell Responses to Influenza to Improve the Influenza$407,002
U19 · FY2016 · AI · contact PI
Exploring the mechanistic basis for altered peripheral B cell selection in SLE$300,162
U19 · FY2016 · AI · contact PI
Monoclonal Antibody Core$238,589
U19 · FY2016 · AI · contact PI
Monoclonal Antibody Technology Core$472,356
P01 · FY2015 · AI · contact PI
Understanding Human B Cell Responses to Influenza to Improve the Influenza$343,170
U19 · FY2015 · AI · contact PI
Exploring the mechanistic basis for altered peripheral B cell selection in SLE$303,603
U19 · FY2015 · AI · contact PI
Monoclonal Antibody Core$201,170
U19 · FY2015 · AI · contact PI
Understanding Human B Cell Responses to Influenza to Improve the Influenza$414,375
U19 · FY2014 · AI · contact PI
Monoclonal Antibody Technology Core$363,624
P01 · FY2014 · AI · contact PI
Exploring the mechanistic basis for altered peripheral B cell selection in SLE$308,100
U19 · FY2014 · AI · contact PI
Monoclonal Antibody Core$242,911
U19 · FY2014 · AI · contact PI
Human Monoclonal Antibodies$549,448
U19 · FY2013 · AI · contact PI
Monoclonal Antibody Technology Core$458,538
P01 · FY2013 · AI · contact PI
Autoimmunity Lymphocyte Repertoire Core (ALRC)$199,866
U19 · FY2013 · AI · contact PI
The Role of Natural Human Anergic B cells in Systemic Lupus Erythematosus Patholo$168,159
U19 · FY2013 · AI · contact PI
Human Monoclonal Antibodies$587,675
U19 · FY2012 · AI · contact PI
Monoclonal Antibody Technology Core$497,827
P01 · FY2012 · AI · contact PI
Early Plasma Cells as a Source of Anthrax-Neutralizing Antibodies$333,451
U19 · FY2012 · AI · contact PI
Autoimmunity Lymphocyte Repertoire Core (ALRC)$218,968
U19 · FY2012 · AI · contact PI
The Role of Natural Human Anergic B cells in Systemic Lupus Erythematosus Patholo$177,851
U19 · FY2012 · AI · contact PI
Human Monoclonal Antibodies$547,977
U19 · FY2011 · AI · contact PI
The origin and consequences of receptor editing and allelic-inclusion.$377,339
R01 · FY2011 · AI · contact PI
Early Plasma Cells as a Source of Anthrax-Neutralizing Antibodies$331,072
U19 · FY2011 · AI · contact PI
Autoimmunity Lymphocyte Repertoire Core (ALRC)$210,344
U19 · FY2011 · AI · contact PI
The Role of Natural Human Anergic B cells in Systemic Lupus Erythematosus Patholo$180,734
U19 · FY2011 · AI · contact PI
Human Monoclonal Antibodies$580,041
U19 · FY2010 · AI · contact PI
The origin and consequences of receptor editing and allelic-inclusion.$381,150
R01 · FY2010 · AI · contact PI
Early Plasma Cells as a Source of Anthrax-Neutralizing Antibodies$348,649
U19 · FY2010 · AI · contact PI
COBRE: OK MED RES FOUND: P2: REGULATION OF ANTIBODY PRODUCTION TO A AUTOANTIGEN$330,594
P20 · FY2010 · RR · contact PI
Autoimmunity Lymphocyte Repertoire Core (ALRC)$216,613
U19 · FY2010 · AI · contact PI
The Role of Natural Human Anergic B cells in Systemic Lupus Erythematosus Patholo$186,118
U19 · FY2010 · AI · contact PI
Human Monoclonal Antibodies$555,504
U19 · FY2009 · AI · contact PI
The origin and consequences of receptor editing and allelic-inclusion.$385,000
R01 · FY2009 · AI · contact PI
Early Plasma Cells as a Source of Anthrax-Neutralizing Antibodies$346,038
U19 · FY2009 · AI · contact PI
Autoimmunity Lymphocyte Repertoire Core (ALRC)$218,799
U19 · FY2009 · AI · contact PI
The Role of Natural Human Anergic B cells in Systemic Lupus Erythematosus Patholo$187,999
U19 · FY2009 · AI · contact PI
The origin and consequences of receptor editing and allelic-inclusion.$385,000
R01 · FY2008 · AI · contact PI
COBRE: OK MED RES FOUND: P2: REGULATION OF ANTIBODY PRODUCTION TO A AUTOANTIGEN$255,638
P20 · FY2007 · RR · contact PI
COBRE: OK MED RES FOUND: P2: REGULATION OF ANTIBODY PRODUCTION TO A AUTOANTIGEN$261,885
P20 · FY2006 · RR · contact PI
COBRE: OK MED RES FOUND: P2: REGULATION OF ANTIBODY PRODUCTION TO A AUTOANTIGEN$215,188
P20 · FY2005 · RR
COBRE: OMRF: B CELL TOLERANCE--SECONDARY IMMUNE RESPONSE$117,169
P20 · FY2005 · RR
COBRE: OK MED RES FOUND: P2: REGULATION OF ANTIBODY PRODUCTION TO A AUTOANTIGEN$198,719
P20 · FY2004 · RR
COBRE: OMRF: B CELL TOLERANCE DURING SECONDARY IMMUNE RESPONSES$166,948
P20 · FY2004 · RR